Clinical Trial Update: Safety & Efficacy of Peginesatide for the Treatment of Anemia in Participants With Chronic Renal Failure Not on Dialysis [Phase 3]

View source ↗

Summary

Phase 3 trial results evaluate safety and efficacy of peginesatide for anemia in patients with chronic kidney disease not on dialysis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• Chronic Kidney Disease

Drugs mentioned

• OMontys (peginesatide)

Snippet

Sponsor: Affymax | Conditions: Chronic Renal Failure, Chronic Kidney Disease | Phase 3 | Status: COMPLETED | Results posted: 2012-07-30